PRiME Seminars in AI and Drug Discovery
💊 PRiME Seminars in AI and Drug Discovery
🚀 Unlocking the Future of Therapeutics
Join us for the next session in our newly launched seminar series exploring how artificial intelligence is transforming drug discovery. From molecular design to clinical prediction, each session brings leading researchers, innovators, and industry experts to share cutting edge insights.
📅 When
Wednesday, October 14, 2026
3-4 pm
📍 Where
Leslie Dan Faculty of Pharmacy
Room 850, 8th floor
144 College St.
University of Toronto
🎤 Upcoming Speaker
Dr. Philip Kim
Professor, Canada Research Chair Tier 1, University of Toronto
CTO, Co-founder, Fable Therapeutics
Talk Title TBC
Philip M. Kim is a professor at the University of Toronto at the Donnelly Centre and the Departments of Computer Science and Molecular Genetics, as well as the Chief Technology Officer of Fable Therapeutics, a biotechnology startup company using AI methods to develop biologics. Fable is developing its own pipeline of therapeutics in the metabolic space and has offices in Toronto and Boston.
In his academic research, Dr. Kim has been developing novel machine learning methods for protein and peptide engineering and authored over 100 publications, 7 invention disclosures and 5 patent applications. He has co-founded several biotechnology companies, including Fable Therapeutics and TBG Therapeutics and serves as consultant and member of the scientific advisory board for others.
Before setting up his lab in 2009, he was a postdoctoral fellow at Yale University and an associate with McKinsey & Co. He holds a Ph.D. from the Artificial Intelligence Laboratory and Department of Chemistry at the Massachusetts Institute of Technology and a B.S. in Physics and Biochemistry from the University of Tuebingen.
🔗 Registration & Details
Everyone is welcome to attend.
Graduate students interested in having their attendance at these seminars on their transcript can sign up for the seminar course PHM3100 (0.13 FCE: CR/NCR). All students are welcome to join, but since the deadline for registration has passed, request access to the course using the Course Add/Drop form that you submit to your grad program coordinator.
Hybrid available on demand. Link will be provided upon request, please contact prime.initiative@utoronto.ca.
For more information, please contact organizer:
Carolyn Cummins, PhD
Associate Professor, Pharmaceutical Sciences